Associated Papers
Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients.
Srinivas L et al.
Frontiers in Pharmacology, 2021
Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results.
Di Francia R et al.
Frontiers in Pharmacology, 2017
Effects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patients.
Guo C et al.
Biomedical Reports, 2015
Lack of an effect of CYP3A4 and MDR1 gene polymorphisms on colchicine pharmacogenetics in the treatment of Familial Mediterranean fever.
Dogruer D et al.
Genetics and Molecular Research : Gmr, 2013
Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation.
Díaz-Molina B et al.
Transplantation Proceedings, 2012
Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.
Sai K et al.
Expert Opinion on Drug Metabolism & Toxicology, 2011
Influence of genetic variation in CYP3A4 and ABCB1 on dose decrease or switching during simvastatin and atorvastatin therapy.
Becker ML et al.
Pharmacoepidemiology and Drug Safety, 2010
Cytochrome P450 2B6 516G-->T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population.
Mahungu T et al.
Hiv Medicine, 2009
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation.
Zanger UM et al.
Analytical and Bioanalytical Chemistry, 2008
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients.
Hesselink DA et al.
Pharmacogenetics and Genomics, 2008
Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib.
Gardner ER et al.
Clinical Pharmacology and Therapeutics, 2006
Predicting drug response and toxicity based on gene polymorphisms.
Robert J et al.
Critical Reviews in Oncology/hematology, 2005
Select a paper to view details